
### [Orphanet:466658](http://www.orpha.net/ORDO/Orphanet_466658)
**Label:** Rare disease with malignant hyperthermia

**Subclasses:** [Orphanet:168572](http://www.orpha.net/ORDO/Orphanet_168572) (Native American myopathy), [Orphanet:99741](http://www.orpha.net/ORDO/Orphanet_99741) (King-Denborough syndrome), [Orphanet:2215](http://www.orpha.net/ORDO/Orphanet_2215) (Multiple pterygium-malignant hyperthermia syndrome), [Orphanet:423](http://www.orpha.net/ORDO/Orphanet_423) (Malignant hyperthermia of anesthesia), [Orphanet:598](http://www.orpha.net/ORDO/Orphanet_598) (Multiminicore myopathy), 

**Corr. equiv. classes:** [OMIM:602771](http://purl.obolibrary.org/obo/OMIM_602771), [OMIM:600467](http://purl.obolibrary.org/obo/OMIM_600467), [OMIM:117000](http://purl.obolibrary.org/obo/OMIM_117000), [OMIM:601887](http://purl.obolibrary.org/obo/OMIM_601887), [OMIM:154275](http://purl.obolibrary.org/obo/OMIM_154275), [OMIM:154276](http://purl.obolibrary.org/obo/OMIM_154276), [OMIM:601888](http://purl.obolibrary.org/obo/OMIM_601888), [OMIM:255320](http://purl.obolibrary.org/obo/OMIM_255320), [OMIM:145600](http://purl.obolibrary.org/obo/OMIM_145600), [Orphanet:423](http://www.orpha.net/ORDO/Orphanet_423), [OMIM:217150](http://purl.obolibrary.org/obo/OMIM_217150), [OMIM:255995](http://purl.obolibrary.org/obo/OMIM_255995), [Orphanet:99741](http://www.orpha.net/ORDO/Orphanet_99741), [Orphanet:598](http://www.orpha.net/ORDO/Orphanet_598), [Orphanet:168572](http://www.orpha.net/ORDO/Orphanet_168572), [Orphanet:2215](http://www.orpha.net/ORDO/Orphanet_2215), 

**Class expressions from DL-Learner:**

- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 56.03%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 53.96%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) 53.06%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) 52.89%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 52.89%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 52.89%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 50.30%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) 50.30%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 47.90%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 47.90%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 45.83%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) 44.49%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 42.65%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue) 41.37%
- [HP:0001371](http://purl.obolibrary.org/obo/HP_0001371) (Flexion contracture) and [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) 41.37%


